Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Dieter Pöhlau"'
Autor:
Matthias Schwab, Andrew Chan, Anna-Katharina Eser, Boris Kallmann, Dieter Pöhlau, Joachim Richter, Torsten B. Wagner, Christoph Grothe
Publikováno v:
Neurology and Therapy, Vol 13, Iss 3, Pp 641-653 (2024)
Abstract Introduction Treatment adherence is a critical success factor in the disease-modifying therapy (DMT) of multiple sclerosis (MS). The REBISTART study prospectively evaluated adherence in patients using components of a patient support program
Externí odkaz:
https://doaj.org/article/37e20567ddba4394b0fa4dbb255d5e11
Autor:
Firas Fneish, Niklas Frahm, Melanie Peters, David Ellenberger, Judith Haas, Micha Löbermann, Dieter Pöhlau, Anna-Lena Röper, Sarah Schilling, Alexander Stahmann, Herbert Temmes, Friedemann Paul, Uwe K. Zettl
Publikováno v:
Vaccines, Vol 11, Iss 12, p 1859 (2023)
Several studies reported post-SARS-CoV-2-vaccination (PV) symptoms. Even people with multiple sclerosis (PwMS) have concerns about disease activity following the SARS-CoV-2 vaccination. We aimed to determine the proportion of PwMS with PV relapses, t
Externí odkaz:
https://doaj.org/article/fd7179958544494b9322499460d272e4
Autor:
Niklas Frahm, Firas Fneish, David Ellenberger, Judith Haas, Micha Loebermann, Tina Parciak, Melanie Peters, Dieter Pöhlau, Jeff Rodgers, Anna-Lena Röper, Sarah Schilling, Alexander Stahmann, Herbert Temmes, Uwe K. Zettl, Rodden M. Middleton
Publikováno v:
The Lancet Regional Health. Europe, Vol 22, Iss , Pp 100502- (2022)
Summary: Background: Vaccines offer people with multiple sclerosis (PwMS) an effective protection against severe COVID-19 disease courses. However, representative real-world data on the tolerability of SARS-CoV-2 vaccines in PwMS are limited. We aime
Externí odkaz:
https://doaj.org/article/9a6b3486974f4051a56463f363e21125
Autor:
Geert Mayer, Svenja Happe, Stefan Evers, Wiebke Hermann, Sabine Jansen, Ulf Kallweit, Maria-Lucia Muntean, Dieter Pöhlau, Dieter Riemann, Michael Saletu, Melanie Schichl, Wolfgang J. Schmitt, Friederike Sixel-Döring, Peter Young
Publikováno v:
Neurological Research and Practice, Vol 3, Iss 1, Pp 1-12 (2021)
Abstract Insomnia is defined as difficulties of initiating and maintaining sleep, early awakening and poor subjective sleep quality despite adequate opportunity and circumstances for sleep with impairment of daytime performance. These components of i
Externí odkaz:
https://doaj.org/article/7ab4fcc902914e5fa465ef5de80f2ab4
Autor:
Paulus Stefan Rommer, David Ellenberger, Kerstin Hellwig, Judith Haas, Dieter Pöhlau, Alexander Stahmann, Uwe Klaus Zettl
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 13 (2020)
Background: Multiple sclerosis (MS) is an inflammatory and neurodegenerative disease whose aetiology is not fully understood. The female sex is clearly predominant, with a sex ratio between 2 and 3. In primary progressive MS the sex ratio almost bala
Externí odkaz:
https://doaj.org/article/5f6a73843bba4018bce56492ce33e7b6
Autor:
Vanessa Wollenweber, Marion Drache, Sabine Schickendantz, Andreas Gerber-Grote, Petra Schiller, Dieter Pöhlau
Publikováno v:
Contemporary Clinical Trials Communications, Vol 3, Iss C, Pp 6-11 (2016)
Background: Hippotherapy is a form of therapeutic riding which is used in the treatment of neurological and muscular disorders. Until now there has not been any high-quality randomised study that has proven its effectiveness. Objective: The aims of t
Externí odkaz:
https://doaj.org/article/d8577c12bbed420f95c2fe9564018428
Autor:
Kerstin Hansen, Katrin Schüssel, Marita Kieble, Johanna Werning, Martin Schulz, Robert Friis, Dieter Pöhlau, Norbert Schmitz, Joachim Kugler
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0133279 (2015)
Long-term therapies such as disease modifying therapy for Multiple Sclerosis (MS) demand high levels of medication adherence in order to reach acceptable outcomes. The objective of this study was to describe adherence to four disease modifying drugs
Externí odkaz:
https://doaj.org/article/1259d85d3a63499eb7a8b9790ea4afc5
Autor:
Ulf Kallweit, Christian R. Baumann, Michael Harzheim, Hildegard Hidalgo, Dieter Pöhlau, Claudio L. Bassetti, Michael Linnebank, Philipp O. Valko
Publikováno v:
Multiple Sclerosis International, Vol 2013 (2013)
Background. Fatigue in patients with multiple sclerosis (MS) is highly prevalent and severely impacts quality of life. Recent studies suggested that sleep-disordered breathing (SDB) significantly contributes to fatigue in MS. Study Objective. To eval
Externí odkaz:
https://doaj.org/article/52f067097be649028031418c746f2bbb
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 3 (2010)
Externí odkaz:
https://doaj.org/article/ff084a8f846d468e8f1c4965c66bb1a9
Autor:
Niklas Frahm, Firas Fneish, David Ellenberger, Judith Haas, Micha Löbermann, Melanie Peters, Dieter Pöhlau, Anna-Lena Röper, Sarah Schilling, Alexander Stahmann, Herbert Temmes, Friedemann Paul, Uwe Klaus Zettl
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 11; Pages: 3640
Despite protection from severe COVID-19 courses through vaccinations, some people with multiple sclerosis (PwMS) are vaccination-hesitant due to fear of post-vaccination side effects/increased disease activity. The aim was to reveal the frequency and